380 related articles for article (PubMed ID: 28818782)
1. Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy.
Pan G; Jia TT; Huang QX; Qiu YY; Xu J; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2017 Nov; 159():375-385. PubMed ID: 28818782
[TBL] [Abstract][Full Text] [Related]
2. Increasing the anticancer performance of bufalin (BUF) by introducing an endosome-escaping polymer and tumor-targeting peptide in the design of a polymeric prodrug.
Shi XJ; Qiu YY; Yu H; Liu C; Yuan YX; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2018 Jun; 166():224-234. PubMed ID: 29602078
[TBL] [Abstract][Full Text] [Related]
3. UV-light cross-linked and pH de-cross-linked coumarin-decorated cationic copolymer grafted mesoporous silica nanoparticles for drug and gene co-delivery in vitro.
Zhou S; Ding C; Wang C; Fu J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110469. PubMed ID: 31923958
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer.
Liu T; Huang Q
Int J Pharm; 2016 Sep; 511(2):1002-11. PubMed ID: 27521701
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent pH-sensing organic/inorganic hybrid mesoporous silica nanoparticles with tunable redox-responsive release capability.
Wan X; Wang D; Liu S
Langmuir; 2010 Oct; 26(19):15574-9. PubMed ID: 20839827
[TBL] [Abstract][Full Text] [Related]
6. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic multiarm star block copolymer-based multifunctional unimolecular micelles for cancer targeted drug delivery and MR imaging.
Li X; Qian Y; Liu T; Hu X; Zhang G; You Y; Liu S
Biomaterials; 2011 Sep; 32(27):6595-605. PubMed ID: 21663960
[TBL] [Abstract][Full Text] [Related]
8. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Mesoporous Silica Nanoparticles Grafted with 2-(tert-butylamino)ethyl Methacrylate-b-poly(ethylene Glycol) Methyl Ether Methacrylate Diblock Brushes as Drug Nanocarrier.
Alswieleh AM; Beagan AM; Alsheheri BM; Alotaibi KM; Alharthi MD; Almeataq MS
Molecules; 2020 Jan; 25(1):. PubMed ID: 31947738
[TBL] [Abstract][Full Text] [Related]
12. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging.
Hu J; Qian Y; Wang X; Liu T; Liu S
Langmuir; 2012 Jan; 28(4):2073-82. PubMed ID: 22047551
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
[TBL] [Abstract][Full Text] [Related]
14. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
15. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles for efficient rivastigmine hydrogen tartrate delivery into SY5Y cells.
Karimzadeh M; Rashidi L; Ganji F
Drug Dev Ind Pharm; 2017 Apr; 43(4):628-636. PubMed ID: 28043167
[TBL] [Abstract][Full Text] [Related]
17. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
18. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J
J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340
[TBL] [Abstract][Full Text] [Related]
19. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
20. Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21-expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma.
Abrishami A; Bahrami AR; Saljooghi AS; Matin MM
Nanoscale; 2024 Mar; 16(12):6215-6240. PubMed ID: 38446130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
